Results 151 to 160 of about 23,326 (221)

Comorbidities as a Personalized Target in Patients with Severe Asthma Treated with Dupilumab [PDF]

Carlota Gonzalez-Lluch, María Basagaña, Laura Pardo, Paula Toro, Agnes Hernández-Biette, Carlos Martínez‐Rivera, Ignasi García-Olivé   +6 more
openalex   +1 more source

The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases - psoriasis and atopic dermatitis. [PDF]

Ann Med
Lemiesz P, Nowowiejska-Purpurowicz J, Flisiak I.   +2 more
europepmc   +1 more source

Predictive value of tissue eosinophilia for dupilumab response in chronic rhinosinusitis with nasal polyps: A retrospective monocentric study [PDF]

Gian Marco Pace, Giulia Mari, Francesco Giombi, Michele Cerasuolo, Camilla Zimello, Luca Cerri, Giorgio Walter Canonica, Enrico Heffler, Giovanni Paoletti, Francesca Puggioni, Barbara Fiamengo, Silvia Uccella, Giuseppe Mercante, Giuseppe Spriano, Luca Malvezzi   +14 more
openalex   +1 more source

Dupilumab for atopic manifestations in pediatric patients with inborn errors of immunity: efficacy and safety in a genetically diverse cohort. [PDF]

Front Immunol
Alsediq N, Algholaiqa T, Alnami G, AlJaber AN.   +3 more
europepmc   +1 more source

Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP [PDF]

Audrey Pelletier, Léandra Mfuna Endam, Emmanuel González, Sufia Jannat, Thea Irani, Martin Desrosiers   +5 more
openalex   +1 more source

Response to comments on "Effectiveness of transitioning from omalizumab to dupilumab in chronic spontaneous urticaria patients with inadequate response to omalizumab". [PDF]

World Allergy Organ J
Hayama K, Ito-Watanabe M, Fujita H.
europepmc   +1 more source

Targeting the IL-4/IL-4R Axis in Th2 Inflammatory Diseases: A Review of Clinical Efficacy and Safety. [PDF]

J Inflamm Res
Li W.
europepmc   +1 more source

Use of Dupilumab to Manage Antibody-Drug Conjugate–Induced Cutaneous Toxicities

Ian Nykaza, Stephen W. Dusza, Jacob Rosenberg, Gopa Iyer, Emily Feld, Sarat Chandarlapaty, Komal Jhaveri, Kristine Peregrino Lacuna, Devika Gajria, Megan Bielawa, Alina Markova, Allison Gordon   +11 more
openalex   +2 more sources

Impact of prednisolone tapering and extended dupilumab dosing intervals on comorbid asthma in patients with chronic rhinosinusitis with nasal polyps. [PDF]

J Allergy Clin Immunol Glob
Minagawa S, Yoshida M, Nakashima D, Numata T, Inukai S, Maruyama T, Adachi T, Araya J, Matsuwaki Y.   +8 more
europepmc   +1 more source

Commentary: Response to “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study” [PDF]

Tien V. Nguyen, Andrea Fleisch Marcus, Sarah‐Jo Sinnott, Anna Coleman, C. Peralta, Stephane Levy, Prashant Kushwaha, Debra Sierka, Marius Ardeleanu, Ana B. Rossi   +9 more
openalex   +1 more source